MucoLife Therapeutics secures investment and partners with US-based Health Wildcatters Accelerator to advance a first-in-class treatment for COPD

GU Ventures
Written by Lindsey Settles

Read More

Lindsey Settles
Previous

BioNTX Unveils 2024 Rising Stars: 8 Innovative North Texas Companies Shaping Life Sciences
Next

Health Wildcatters Adds Nine Startups, Boosting Its Portfolio to 118 Companies » Dallas Innovates